A Real‐World Study Characterizing a US Population of Patients Receiving Rituximab With Gemcitabine and Oxaliplatin for Relapsed or Refractory Large B‐Cell Lymphoma
L Elizabeth Budde, Adam J Olszewski, Bei Hu, Nikesh N Shah, Connie Lee Batlevi, Shen Yin, Iris To, Michael C Wei, Martine Joanna Kallemeijn, Lisa Musick, Linda Lundberg, Natasha Shamas, Mark Dixon, Navdeep Pal, Ashwini Shewade, Jason Westin · 2026
Read A Real‐World Study Characterizing a US Population of Patients Receiving Rituximab With Gemcitabine and Oxaliplatin for Relapsed or Refractory Large B‐Cell Lymphoma by L Elizabeth Budde, Adam J Olszewski, Bei Hu, Nikesh N Shah, Connie Lee Batlevi, Shen Yin, Iris To, Michael C Wei, Martine Joanna Kallemeijn, Lisa Musick, Linda Lundberg, Natasha Shamas, Mark Dixon, Navdeep Pal, Ashwini Shewade, Jason Westin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13472062.txt.
Description
L Elizabeth Budde and co-authors describe how a three-drug salvage regimen performs in everyday United States lymphoma care, in a 2026 study. Rituximab with gemcitabine and oxaliplatin is a standard fallback when large B-cell lymphoma returns, yet community data were thin. Health records for 281 patients treated from 2011 to 2023, mostly in community clinics, supplied the picture.
About forty-five percent responded and twenty-two percent cleared the cancer completely, but the typical patient progressed within three months and lived about a year. Those treated at first relapse did clearly better than patients treated later. The authors offer the numbers as a real-world benchmark for judging newer options.
Catalog record
| CREATOR | L Elizabeth Budde, Adam J Olszewski, Bei Hu, Nikesh N Shah, Connie Lee Batlevi, Shen Yin, Iris To, Michael C Wei, Martine Joanna Kallemeijn, Lisa Musick, Linda Lundberg, Natasha Shamas, Mark Dixon, Navdeep Pal, Ashwini Shewade, Jason Westin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |